These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

115 related articles for article (PubMed ID: 9630001)

  • 1. A detailed characterization of the effects of four cannabinoid agonists on operant lever pressing.
    Carriero D; Aberman J; Lin SY; Hill A; Makriyannis A; Salamone JD
    Psychopharmacology (Berl); 1998 May; 137(2):147-56. PubMed ID: 9630001
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Discriminative stimulus effects of the cannabinoid CB1 antagonist SR 141716A in rhesus monkeys pretreated with Delta9-tetrahydrocannabinol.
    McMahon LR
    Psychopharmacology (Berl); 2006 Oct; 188(3):306-14. PubMed ID: 16953389
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Characterization of cannabinoid agonists and apparent pA2 analysis of cannabinoid antagonists in rhesus monkeys discriminating Delta9-tetrahydrocannabinol.
    McMahon LR
    J Pharmacol Exp Ther; 2006 Dec; 319(3):1211-8. PubMed ID: 16943255
    [TBL] [Abstract][Full Text] [Related]  

  • 4. JWH-018 in rhesus monkeys: differential antagonism of discriminative stimulus, rate-decreasing, and hypothermic effects.
    Rodriguez JS; McMahon LR
    Eur J Pharmacol; 2014 Oct; 740():151-9. PubMed ID: 24972243
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Differentiation between low- and high-efficacy CB1 receptor agonists using a drug discrimination protocol for rats.
    Järbe TU; LeMay BJ; Halikhedkar A; Wood J; Vadivel SK; Zvonok A; Makriyannis A
    Psychopharmacology (Berl); 2014 Feb; 231(3):489-500. PubMed ID: 24005529
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Cannabinoid agonists differentially substitute for the discriminative stimulus effects of Delta(9)-tetrahydrocannabinol in C57BL/6J mice.
    McMahon LR; Ginsburg BC; Lamb RJ
    Psychopharmacology (Berl); 2008 Jul; 198(4):487-95. PubMed ID: 17673980
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Partial agonist-like profile of the cannabinoid receptor antagonist SR141716A in a food-reinforced operant paradigm.
    De Vry J; Jentzsch KR
    Behav Pharmacol; 2004 Feb; 15(1):13-20. PubMed ID: 15075622
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Activation of brain prostanoid EP3 receptors via arachidonic acid cascade during behavioral suppression induced by Delta8-tetrahydrocannabinol.
    Yamaguchi T; Kubota T; Watanabe S; Yamamoto T
    J Neurochem; 2004 Jan; 88(1):148-54. PubMed ID: 14675158
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Differential effects of delta9-tetrahydrocannabinol and methanandamide in CB1 knockout and wild-type mice.
    Baskfield CY; Martin BR; Wiley JL
    J Pharmacol Exp Ther; 2004 Apr; 309(1):86-91. PubMed ID: 14718593
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Cannabinoid agonists but not inhibitors of endogenous cannabinoid transport or metabolism enhance the reinforcing efficacy of heroin in rats.
    Solinas M; Panlilio LV; Tanda G; Makriyannis A; Matthews SA; Goldberg SR
    Neuropsychopharmacology; 2005 Nov; 30(11):2046-57. PubMed ID: 15870833
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Behavioral effects of cannabinoids show differential sensitivity to cannabinoid receptor blockade and tolerance development.
    De Vry J; Jentzsch KR; Kuhl E; Eckel G
    Behav Pharmacol; 2004 Feb; 15(1):1-12. PubMed ID: 15075621
    [TBL] [Abstract][Full Text] [Related]  

  • 12. (R)-methanandamide and Delta 9-THC as discriminative stimuli in rats: tests with the cannabinoid antagonist SR-141716 and the endogenous ligand anandamide.
    Järbe TU; Lamb RJ; Lin S; Makriyannis A
    Psychopharmacology (Berl); 2001 Aug; 156(4):369-80. PubMed ID: 11498713
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Cross-tolerance between delta-9-tetrahydrocannabinol and the cannabimimetic agents, CP 55,940, WIN 55,212-2 and anandamide.
    Pertwee RG; Stevenson LA; Griffin G
    Br J Pharmacol; 1993 Dec; 110(4):1483-90. PubMed ID: 8306090
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Receptor mechanism and antiemetic activity of structurally-diverse cannabinoids against radiation-induced emesis in the least shrew.
    Darmani NA; Janoyan JJ; Crim J; Ramirez J
    Eur J Pharmacol; 2007 Jun; 563(1-3):187-96. PubMed ID: 17362921
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Delta9-THC training dose as a determinant for (R)-methanandamide generalization in rats: a systematic replication.
    Järbe TU; Lamb RJ; Lin S; Makriyannis A
    Behav Pharmacol; 2000 Feb; 11(1):81-6. PubMed ID: 10821212
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Internalization and recycling of the CB1 cannabinoid receptor.
    Hsieh C; Brown S; Derleth C; Mackie K
    J Neurochem; 1999 Aug; 73(2):493-501. PubMed ID: 10428044
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Evaluation of the role of nicotinic acetylcholine receptor subtypes and cannabinoid system in the discriminative stimulus effects of nicotine in rats.
    Zaniewska M; McCreary AC; Przegaliński E; Filip M
    Eur J Pharmacol; 2006 Jul; 540(1-3):96-106. PubMed ID: 16730696
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Time course of the effects of different cannabimimetics on prolactin and gonadotrophin secretion: evidence for the presence of CB1 receptors in hypothalamic structures and their involvement in the effects of cannabimimetics.
    Fernández-Ruiz JJ; Muñoz RM; Romero J; Villanua MA; Makriyannis A; Ramos JA
    Biochem Pharmacol; 1997 Jun; 53(12):1919-27. PubMed ID: 9256167
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Development of cross-tolerance between delta 9-tetrahydrocannabinol, CP 55,940 and WIN 55,212.
    Fan F; Compton DR; Ward S; Melvin L; Martin BR
    J Pharmacol Exp Ther; 1994 Dec; 271(3):1383-90. PubMed ID: 7996450
    [TBL] [Abstract][Full Text] [Related]  

  • 20. (R)-methanandamide, but not anandamide, substitutes for delta 9-THC in a drug-discrimination procedure.
    Burkey RT; Nation JR
    Exp Clin Psychopharmacol; 1997 Aug; 5(3):195-202. PubMed ID: 9260067
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.